Search results
Results from the WOW.Com Content Network
United Therapeutics Corporation is an American publicly traded biotechnology company [2] and public benefit corporation [3] listed on the NASDAQ under the symbol UTHR. [4] [5] It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing.
According to the North Carolina Biotechnology Center, North Carolina is home to 528 biotechnology companies that provide 57,000 jobs and $1.92 billion in taxes for state and local government. [3] Employment in the industry has grown 4.1% from 2008 to 2010, when other industries shed thousands of jobs. [ 4 ]
The North Carolina Biotechnology Center is a non-profit, public-private partnership organization located in Research Triangle Park (North Carolina, United States).Founded in 1984 by the North Carolina General Assembly, it was the first state-sponsored biotechnology initiative in the United States, merging the interests of the academic private and public sectors. [1]
A biologics license application (BLA) is defined by the U.S. Food and Drug Administration (FDA) as follows: The biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680.
Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina. [2] Locus develops phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Cas9, delivered by engineered bacteriophages. [5]
Johnson & Johnson, Janseen’s parent company, agreed to invest $1 billion at the site by the end of 2028 — though the corporation says it will exceed its state incentive deal and ultimately ...
Pages in category "Biotechnology companies of the United States" The following 200 pages are in this category, out of approximately 331 total. This list may not reflect recent changes .
Biogen was founded in 1978 in Geneva as Biotechnology Geneva by several prominent biologists, including Kenneth Murray from the University of Edinburgh, Phillip Allen Sharp from the Massachusetts Institute of Technology, Walter Gilbert from Harvard University (Gilbert served as CEO during the start-up phase of Biogen), Heinz Schaller from the University of Heidelberg, and Charles Weissmann ...